The cumulative risk of HIV-1 mother-to-infant transmission at 48 weeks was significantly lower among breast-feeding HIV-positive mothers who received antiretroviral drugs or whose infants received antiretroviral drugs, CDC researchers wrote in the journal The Lancet. The trial in Malawi also found a greater risk of diarrhea, delayed growth, malaria, tuberculosis and death in infants after weaning by 28 weeks.
Antiretroviral drugs during breast-feeding cut HIV transmission
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|